Last month’s leaked U.S. Supreme Court draft majority opinion from Justice Alito in Dobbs v. Jackson Women’s Health Organization that would overturn Roe v. Wade and Planned Parenthood v. Casey could have long reaching effects for health law beyond the obvious liability for providers who are involved in women’s health and abortion. If the opinion does reflect the judgment of a majority of the Court, then it could impact even drug and device companies in ways that were not obvious from the face of the opinion.
Reed Smith has established a working group to evaluate the impact of the decision on our health care and life sciences clients. The group includes our products liability colleagues who author the Drug and Device Law Blog and have written a post about how the Court’s supposed action would affect medical product manufacturers.
That post is available on the Drug and Device Law Blog here.
Reed Smith will continue following developments as the Supreme Court term comes to a close this month. If you have any questions about what impact this pending decision may have on your practice or business or what the Court’s opinion will mean for you when it does eventually come out, please contact the health care lawyers at Reed Smith.